Preeclampsia Predicts Risk of Hospitalization for Heart Failure With Preserved Ejection Fraction

被引:39
|
作者
Williams, Dominique [1 ]
Stout, Molly J. [2 ]
Rosenbloom, Joshua, I [3 ]
Olsen, Margaret A. [4 ]
Maddox, Karen E. Joynt [1 ]
Deych, Elena [1 ]
Davila-Roman, Victor G. [1 ]
Lindley, Kathryn J. [1 ,3 ]
机构
[1] Washington Univ, Cardiovasc Div, Cardiovasc Imaging & Clin Res Core Lab, St Louis, MO 63110 USA
[2] Univ Michigan, Dept Obstet & Gynecol, Div Maternal Fetal Med, Ann Arbor, MI USA
[3] Washington Univ, Div Maternal Fetal Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA
[4] Washington Univ, Dept Surg, Div Infect Dis, Div Publ Hlth Sci,Dept Med, St Louis, MO 63110 USA
基金
美国国家卫生研究院; 美国医疗保健研究与质量局;
关键词
heart failure; HFpEF; preeclampsia; pregnancy; women; HYPERTENSIVE DISORDERS; CARDIOVASCULAR-DISEASE; PREGNANCY; MANAGEMENT;
D O I
10.1016/j.jacc.2021.09.1360
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Preeclampsia is associated with increased risk of future heart failure (HF), but the relationship between preeclampsia and HF subtypes are not well-established. OBJECTIVES The objective of this analysis was to identify the risk of HF with preserved ejection fraction (HFpEF) following a delivery complicated by preeclampsia/eclampsia. METHODS A retrospective cohort study using the New York and Florida state Healthcare Cost and Utilization Project State Inpatient Databases identified delivery hospitalizations between 2006 and 2014 for women with and without preeclampsia/eclampsia. The authors identified women admitted for HF after discharge from index delivery hospitalization until September 30, 2015, using International Classification of Diseases-9th Revision-Clinical Modification diagnosis codes. Patients were followed from discharge to the first instance of primary outcome (HFpEF hospitalization), death, or end of study period. Secondary outcomes included hospitalization for any HF and HF with reduced ejection fraction, separately. The association between preeclampsia/eclampsia and HFpEF was analyzed using Cox proportional hazards models. RESULTS There were 2,532,515 women included in the study: 2,404,486 without and 128,029 with preeclampsia/eclampsia. HFpEF hospitalization was significantly more likely among women with preeclampsia/eclampsia, after adjusting for baseline hypertension and other covariates (aHR: 2.09; 95% CI: 1.80-2.44). Median time to onset of HFpEF was 32.2 months (interquartile range: 0.3-65.0 months), and median age at HFpEF onset was 34.0 years (interquartile range: 29.0-39.0 years). Both traditional (hypertension, diabetes mellitus) and sociodemographic (Black race, rurality, low income) risk factors were also associated with HFpEF and secondary outcomes. CONCLUSIONS Preeclampsia/eclampsia is an independent risk factor for future hospitalizations for HFpEF. (C) 2021 by the American College of Cardiology Foundation.
引用
收藏
页码:2281 / 2290
页数:10
相关论文
共 50 条
  • [1] FRAILTY INDEPENDENTLY PREDICTS HOSPITALIZATION BURDEN IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Sareini, Mohamed-Ali
    Hornsby, Whitney
    Alreefi, Fadi
    Konerman, Matthew
    Hummel, Scott L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 835 - 835
  • [2] Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction
    Yang, Eunice
    Vaishnav, Joban
    Song, Evelyn
    Lee, Joan
    Schulman, Steven
    Calkins, Hugh
    Berger, Ronald
    Russell, Stuart D.
    Sharma, Kavita
    ESC HEART FAILURE, 2022, 9 (05): : 3918 - 2927
  • [3] Spironolactone reduces the risk of mortality and hospitalization in veterans with heart failure with preserved ejection fraction
    Kurgansky, Katherine E.
    Parker, Rachel
    Djousse, Luc
    Joseph, Jacob
    Gagnon, David
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 564 - 565
  • [4] Obesity, Cardiorenal Comorbidities, and Risk of Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction
    Morgen, Camilla S.
    Haase, Christiane L.
    Oral, Tugce K.
    Schnecke, Volker
    Varbo, Anette
    Borlaug, Barry A.
    MAYO CLINIC PROCEEDINGS, 2023, 98 (10) : 1458 - 1468
  • [5] The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction)
    Carson, Peter E.
    Anand, Inder S.
    Win, Sithu
    Rector, Thomas
    Haass, Markus
    Lopez-Sendon, Jose
    Miller, Alan
    Teerlink, John R.
    White, Michel
    McKelvie, Robert S.
    Komajda, Michel
    Zile, Michael R.
    McMurray, John J.
    Massie, Barry
    JACC-HEART FAILURE, 2015, 3 (06) : 429 - 441
  • [6] Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction
    Taher M. Mandviwala
    Sukhdeep S. Basra
    Umair Khalid
    June K. Pickett
    Ryle Przybylowicz
    Tina Shah
    Vijay Nambi
    Salim S. Virani
    Anita Deswal
    International Journal of Obesity, 2020, 44 : 1561 - 1567
  • [7] Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction
    Mandviwala, Taher M.
    Basra, Sukhdeep S.
    Khalid, Umair
    Pickett, June K.
    Przybylowicz, Ryle
    Shah, Tina
    Nambi, Vijay
    Virani, Salim S.
    Deswal, Anita
    INTERNATIONAL JOURNAL OF OBESITY, 2020, 44 (07) : 1561 - 1567
  • [8] Aldosterone dysregulation predicts the risk of mortality and rehospitalization in heart failure with a preserved ejection fraction
    Ke, Bingbing
    Tan, Xin
    Ren, Lu
    Fan, Yangkai
    Zhang, Yixin
    Li, Fengjuan
    Sun, Qiqi
    Liu, Tong
    Jia, Lixin
    Wang, Yuan
    Du, Jie
    SCIENCE CHINA-LIFE SCIENCES, 2022, 65 (03) : 631 - 642
  • [9] Aldosterone dysregulation predicts the risk of mortality and rehospitalization in heart failure with a preserved ejection fraction
    Bingbing Ke
    Xin Tan
    Lu Ren
    Yangkai Fan
    Yixin Zhang
    Fengjuan Li
    Qiqi Sun
    Tong Liu
    Lixin Jia
    Yuan Wang
    Jie Du
    Science China Life Sciences, 2022, 65 (03) : 631 - 642
  • [10] Aldosterone dysregulation predicts the risk of mortality and rehospitalization in heart failure with a preserved ejection fraction
    Bingbing Ke
    Xin Tan
    Lu Ren
    Yangkai Fan
    Yixin Zhang
    Fengjuan Li
    Qiqi Sun
    Tong Liu
    Lixin Jia
    Yuan Wang
    Jie Du
    Science China Life Sciences, 2022, 65 : 631 - 642